After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its remaining strategic commitment by reupping a pact with AI drug designer Nabla Bio.

A prestigious science award has been given to a man who created a new generative AI language model capable of identifying the exact chemical structure of designer drugs, even drugs that have not been ...

This process is costly, time-consuming, and has a low success rate. KAIST researchers have developed an AI model that, using only information about the target protein, can design optimal drug ...

The Academy of Motion Picture Arts and Sciences handed out its Technical Achievement awards on Friday night, with Sébastien Deguy, Christophe Soum, Sylvain Paris and Nicolas Wirrmann for Adobe ...

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 9, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and ...